Maryam Parviz and Iman Manavitehrani, co-founders of SDIP Innovations, and currently Rosenman Fellows, announced that their company had been awarded $2.77 million ($AUS) by NSW Health, the biggest public health system in Australia.

On their LinkedIn page, they wrote:

“We are excited to announce that the NSW Health has awarded SDIP Innovations Pty Ltd the amount of $2.77 M to advance JAZBI™ bioresorbable implant systems. The support from NSW Health Medical Devices Fund goes beyond just the Grant. It provides access to the NSW healthcare system resources and critical insights from NSW Health medical devices expert panel. Thanks to the team at the office of health and Medical Research for invaluable guidance and continued support for # #medicaldevices #startup.

We would like to give a shout-out to the team at SDIP; Maryam Parviz, PhD, Iman Manavitehrani, Brett Fritsch, Fred Dinger, Gabriele Niederauer, Mark Q. Niederauer, Shannon Scott, MS, Dr. Mohammad Diab, MD and Ben Wright.

Thanks to our partners/mentors at UCSF Rosenman Institute, in particular, Christine Winoto. Thanks Karen Boezi, the managing director of the Rosenman/QB3 executive mentorship program, for helping in extending our global network–and to our partners Cannon Quality Group, LLC, Nicolle Cannon & Richard Goeb, Kilpatrick Townsend & Stockton LLP`s Babak Kusha, Cicada Innovations team and Cicada MedLab.”

Maryam and Iman graduated with distinction from the Australian State (NSW) Government sponsored “Medical Device Commercialization Training Program,” from which they were jointly awarded a two-year fellowship at the UCSF Rosenman Institute and QB3 incubator. Parviz and Manavitehrani co-founded SDIP Innovations in 2018, currently resident in the QB3 Garage@UCSF incubator in San Francisco.

SDIP Innovations is developing a novel biomaterial platform, JAZBI, for a broad range of orthopaedic and cardiovascular applications. In animal studies, JAZBI is superior to other bioresorbable materials due to its safe degradation into water and carbon dioxide, as well as complete reabsorption from bulk (inside-out), resulting in less inflammation, better healing, and stronger integration with bone. SDIP is initially focused on developing resorbable osteotomies wedges and screws for ACL reconstruction. The technology was co-invented by Dr. Iman Manavitehrani during his PhD at the University of Sydney.